STVN 18.01 Stevanato Group S.p.A.
| Range: | 16.56-34.97 | Vol Avg: | 534900 | Last Div: | 0.06 | Changes: | 0.68 |
| Beta: | 0.58 | Cap: | 5.18B | Currency: | USD | Exchange: | NYSE |
| Sector: | Healthcare | IPO: | Fri Jul 16 2021 | Empoloyees: | 5635 | ||
| CUSIP: | T9224W109 | CIK: | 0001849853 | ISIN: | IT0005452658 | Country: | IT |
| CEO: | Mr. Franco Stevanato | Website: | https://www.stevanatogroup.com | ||||
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.
Stock Details
STVN 28
Stevanato Group price target lowered to $28 from $30 at Citi
Patrick Donnelly·Wed Aug 07 2024
Citigroup
STVN 22
Stevanato Group price target lowered to $22 from $26 at Morgan Stanley
Drew Ranieri·Mon Jul 15 2024
Morgan Stanley
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow